Elevation Oncology (ELEV)
(Real Time Quote from BATS)
$2.91 USD
+0.02 (0.69%)
Updated Jul 26, 2024 03:52 PM ET
After-Market: $2.94 +0.03 (1.03%) 4:10 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.23 |
Last EPS Surprise | -9.52% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.92 |
Next Year | -0.95 |
EPS (TTM) | -1.04 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -0.23 | -0.92 | -0.95 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | -0.19 | -0.20 | -0.82 | -0.83 |
High Estimate | -0.19 | -0.20 | -0.82 | -0.72 |
Low Estimate | -0.27 | -0.26 | -1.01 | -1.32 |
Year ago EPS | -0.37 | -0.25 | -1.34 | -0.92 |
Year over Year Growth Est. | 37.84% | 8.00% | 31.34% | -3.04% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -0.23 | -0.92 | -0.95 |
7 Days Ago | -0.23 | -0.23 | -0.92 | -0.95 |
30 Days Ago | -0.23 | -0.23 | -0.92 | -0.95 |
60 Days Ago | -0.22 | -0.21 | -0.89 | -0.79 |
90 Days Ago | -0.22 | -0.21 | -0.87 | -0.78 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -0.23 | -0.92 | -0.95 |
Zacks Consensus Estimate | -0.23 | -0.23 | -0.92 | -0.95 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.23 | -0.19 | -0.25 | -0.37 | NA |
Estimate | -0.21 | -0.21 | -0.34 | -0.28 | NA |
Difference | -0.02 | 0.02 | 0.09 | -0.09 | 0.00 |
Surprise | -9.52% | 9.52% | 26.47% | -32.14% | -1.42% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more